‘We wish to accelerate our growth with organic and inorganic means to reach Rs 10 billion in sales in the next five years’ Read more
M&A activity in the pharmaceutical market witnessed significant increase in value terms with a focus on high-growth markets Read more
Piramal Healthcare presents positive results of pivotal phase III clinical trial for BST-CarGel Read more